Swords Laboratories

Swords Laboratories is a specialized pharmaceutical manufacturing organization located in Swords, County Dublin, Ireland. Originally a cornerstone of Bristol Myers Squibb's global manufacturing network, the facility was acquired by SK Biotek in 2018 to serve as its European headquarters and primary small molecule API production site. The company operates as a Contract Development and Manufacturing Organization (CDMO), supporting the production of complex active pharmaceutical ingredients for global markets. Its capabilities include advanced chemical synthesis, process development, and large-scale commercial manufacturing under cGMP conditions. The site has a long history of producing high-volume blockbuster medications and continues to be a vital hub for pharmaceutical production in Ireland.